Multi-modal approach to treatment in advanced adrenocortical carcinoma

Combination chemotherapy in advanced adrenocortical carcinoma.

BACKGROUND Adrenocortical carcinoma is a rare cancer that has a poor response to cytotoxic treatment. METHODS We randomly assigned 304 patients with advanced adrenocortical carcinoma to receive mitotane plus either a combination of etoposide (100 mg per square meter of body-surface area on days 2 to 4), doxorubicin (40 mg per square meter on day 1), and cisplatin (40 mg per square meter on da...

Developing treatment for adrenocortical carcinoma.

Cancer of the adrenal cortex (ACC) is a rare endocrine malignancy with limited treatment options. Patients typically present with autonomous hormonal overproduction and/or a large abdominal mass. Hormonal assays and medical imaging can be diagnostic, but urinary steroid profiling might be a more sensitive technique to assess malignancy in adrenal tumours. The stage of the disease at diagnosis i...

Multimodal Treatment Approach to Advanced Female Urethral Squamous Cell Carcinoma

Introduction and Objectives: Primary squamous cell carcinoma of the female urethra is rare. Given the small number of cases seen, no uniform regimen for optimal treatment has been identified. We set out to review the outcomes of women with advanced urethral squamous cell carcinoma treated with a multimodality approach in order to gain insight into the optimal treatment of this rare malignancy. ...

treatment of advanced prostate carcinoma in kyrgyzstan

A Multi - Modal Approach to Functional Neuroimaging

The work undertaken involves the use of functional magnetic resonance imaging (fMRI) and magnetoencephalography (MEG) as separate but complementary non-invasive functional brain imaging modalities. The aim in combining fMRI and MEG is centred around exploitation of the high temporal resolution available in MEG, and the high spatial resolution available in fMRI. However, whilst MEG represents a ...